SOT and the US FDA Center for Food Safety and Applied Nutrition (CFSAN) cordially invite you to join us for our October colloquium “The Big 8: Advances in Food Allergy Risk Assessment and Management.” This session is open to the public to attend in person or via webcast. These colloquia are not a public forum for discussion of toxicology regulatory issues.
Food allergies are increasing in prevalence and pose a significant public health burden. Major food allergens (The Big 8) are defined in the Food Allergen Labeling and Consumer Protection Act (FALCPA) and also are addressed in the risk-based Preventive Controls for Human Food rule of the FDA Food Safety Modernization Act (FSMA). Yet, presence of incidental and poorly declared levels of allergens in food products continues to present challenges for the food industry, regulators, and consumers and are an important cause of food recalls and accidental allergic reactions. The purpose of this symposium is to explore the latest issues influencing the food allergy risk assessment and management landscape, including: 1) identification and characterization of IgE-mediated allergen hazards, 2) clinical prevention and treatment of food allergies, 3) understanding dose thresholds, and 4) implementation of allergen preventive controls and labeling.
Chair: Stephen Taylor, University of Nebraska, Lincoln, NE
Co-Chair: Stefano Luccioli, US FDA, College Park, MD
October 11, 2018
8:30 am–12:50 pm ET (UTC-4)
Wiley Auditorium, US FDA, College Park, Maryland
Registration for Participation On-Site
Webcast Registration
Colloquium website
Presentations include:
8:30 AM–8:45 AM
|
US FDA Welcome and Overview
TBD, CFSAN, US FDA, College Park, MD
Welcome from SOT and Introductions
Bryan Delaney, SOT FDA Colloqium Committee Chair, Corteva Agriscience™
Agriculture Division of DowDuPont, Johnston, IA
|
8:45 AM–9:25 AM
|
The Public Health Impacts of Food Allergies
Stefano Luccioli, US FDA, CFSAN, College Park, MD
|
9:25 AM–10:05 AM
|
Clinical Management of Food-Allergic Patients: Emerging Prevention and
Treatment Modalities
Matthew Greenhawt, Colorado Children’s Hospital, Denver, CO
|
10:25 AM–11:05 AM
|
How Much Is Too Much? Threshold Dose for Allergenic Foods
Joseph Baumert, University of Nebraska, Lincoln, NE
|
11:05 AM–11:45 AM
|
Food Industry Perspective on Controlling the Risk
Scott Hegenbart, ConAgra Brands, Omaha, NE
|
11:45 AM–12:45 PM
|
Roundtable Discussion |
Questions concerning the regulatory science are solicited from the audience on-site and from webcast participants for the roundtable discussion. Regulatory policy will not be discussed.
The SOT FDA Colloquia on Emerging Toxicological Science: Challenges in Food and Ingredient Safety present scientific training that is high quality, cutting-edge, future-oriented toxicological science for US FDA employees and are open to the public at no cost. However, the colloquia are not a public forum for discussion of toxicology regulatory issues.
Recordings and slides from the previous colloquia are available free via the SOT FDA Colloquia website, including the June 13, 2018, session, “Food from Genetically Engineered Plants: What Role for Metabolomics?”